Spiro derivatives as lipoxygenase inhibitors
US7576094B2 · kind B2 · utility
4Cited by
75References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2005 |
| Grant date | Aug 18, 2009 |
| Priority date | — |
| Expiry date | Jun 22, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is concerned with certain novel spiro substituted heterocylic ring derivatives. These compounds may be useful in the manufacture of pharmaceutical compositions for treating disorders mediated by lipoxygenases. They may also be useful in the manufacture of pharmaceutical formulations for the treatment of lipoxygenase-mediated disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.